BSD Medical Reports Successful Promotion of the MicroThermX® Microwave Ablation System at CIRSE by Terumo Europe N.V.

Published: Oct 09, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ: BSDM) (“Company” or “BSD”), today reported the successful promotion of the MicroThermX® Microwave Ablation System (MicroThermX) at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) conference in Barcelona, Spain. Terumo Europe NV (Terumo), a wholly owned subsidiary of Terumo Corporation, used CIRSE as the main launching pad to showcase BSD's MicroThermX as an integral part of its branded Interventional Oncology Solutions (IOS). CIRSE is the world's largest and most prestigious conference in the field of minimally invasive image-guided therapies.

Help employers find you! Check out all the jobs and post your resume.

Back to news